| 1 |
Sousa EB, Brandao LF, Tavares CB, et al. Epidemiological characteristics of 778 patients who underwent surgical drainage of chronic subdural hematomas in Brasília, Brazil[J]. BMC Surg, 2013, 13 (1): 5.
|
| 2 |
Tabuchi S, Kadowaki M. Chronic subdural hematoma in patients over 90 years old in a super-aged society[J]. J Clin Med Res, 2014, 6 (5): 379-383.
|
| 3 |
Yadav YR, Parihar V, Chourasia ID, et al. The role of subgaleal suction drain placement in chronic subdural hematoma evacuation[J]. Asian J Neurosurg, 2016, 11 (3): 214-218.
|
| 4 |
Santarius T, Kirkpatrick PJ, Kolias AG, et al. Working toward rational and evidence-based treatment of chronic subdural hematoma[J]. Clin Neurosurg, 2010 (57): 112-122.
|
| 5 |
Stanisic M, Lyngstadaas SP, Pripp AH, et al. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study[J]. Acta Neurochir, 2012, 154 (20): 113-120.
|
| 6 |
Kolias AG, Chaff A, Santarius T, et al. Chronic subdural haematoma: modem management and emerging therapies[J]. Nat Rev Neurol, 2014, 10 (10): 570-578.
|
| 7 |
Dong W, Tuo L, Ye T, et al. Effects of atorvastatin on chronic subdural hematoma: a preliminary report from three medical centers[J]. J Neurol Sci, 2014, 336 (12): 237-242.
|
| 8 |
Kuwabara M, Sadatomo T, Yuki K, et al. The effect of irrigation solutions on recurrence of chronic subdural hematoma: a consecutive cohort study of 234 patients[J]. Neurol Med Chir (Tokyo), 2017, 57 (5): 210-216.
|
| 9 |
Stavrinou P, Katsigiannis S, Lee JH, et al. Risk factors for chronic subdural hematoma recurrence identified using quantitative computed tomography analysis of hematoma volume and density[J]. World Neurosurg, 2017 (99): 465-470.
|
| 10 |
Wan Y, Fei X, Jiang D, et al. Clinical observation of treatment of chronic subdural hematoma with novel double needle minimally invasive aspiration technology[J]. J Craniofac Surg, 2017, 28 (3): 646-649.
|
| 11 |
Abecassis IJ, Kim LJ. Craniotomy for treatment of chronic subdural hematoma[J]. Neurosurg Clin N Am, 2017, 28 (2): 229-237.
|
| 12 |
Desai VR, Scranton RA, Britz GW. Management of recurrent subdural hematomas[J]. Neurosurg Clin N Am, 2017, 28 (2): 279-286.
|
| 13 |
Akpinar A, Ucler N, Erdogan U, et al. Epidural hematoma complication after rapid chronic subdural hematoma evacuation: a case report[J]. Am J Case Rep, 2015 (16): 430-433.
|
| 14 |
Schwarz F, Loos F, Dünisch P, et al. Risk factors for reoperation after initial burr hole trephination in chronic subdural hematomas[J]. Clin Neurol Neurosurg, 2015 (138): 66-71.
|
| 15 |
Kutty SA, Johny M. Chronic subdural hematoma: a comparison of recurrence rates following burr-hole craniostomy with and without drains[J]. Turk Neurosurg, 2014, 24 (4): 494-497.
|
| 16 |
Chari A, Kolias AG, Santarius T, et al. Twist-drill craniostomy with hollow screws for evacuation of chronic subdural hematoma[J]. J Neurosurg, 2014, 121 (1): 176-183.
|
| 17 |
Liu H, Liu Z, Liu Y, et al. Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study [RETRACTED][J]. J Neurosurg, 2016 (7): 1-10.
|
| 18 |
Jiang R, Wang D, Poon WS, et al. Effect of atorvastatin on chronic subdural hematoma (ATOCH): a study protocol for a randomized controlled trial[J]. Trials, 2015, 16 (1): 528.
|
| 19 |
Liu H, Luo Z, Liu Z, et al. Atorvastatin may attenuate recurrence of chronic subdural hematoma[J]. Front Neurosci, 2016, (10): 303.
|
| 20 |
Chan DY, Chan DT, Sun TF, et al. The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study[J]. Br J Neurosurg, 2017, 31 (1): 72-77.
|
| 21 |
Pripp AH, Stanisic M. The correlation between pro- and anti-inflammatory cytokines in chronic subdural hematoma patients assessed with factor analysis[J]. PLoS One, 2014, 9 (2): e90149.
|
| 22 |
Zou H, Zhu XX, Ding YH, et al. Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new tricks?[J]. Oncotarget, 2017, 8 (16): 27541-27546.
|
| 23 |
Goto T, Ohshima S, Miura K, et al. A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C[J]. Intern Med, 2013, 52 (18): 2057-2060.
|
| 24 |
傅楚华，陈波，王宁，等. 阿托伐他汀治疗术后复发慢性硬膜下血肿的疗效观察[J/CD]. 中华神经创伤外科电子杂志，2016，2(3):136-139.
|
| 25 |
Wang D, Li T, Wei H, et al. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model[J]. J Neurol Sci, 2016 (362): 91-99.
|
| 26 |
Araujo FA, Rocha MA, Mendes JB, et al. Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1[J] Biomed Pharm, 2010, 64 (1): 29-34.
|
| 27 |
Stumpf C, Petzi S, Seybold K, et al. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction[J]. Clin Sci, 2009, 116 (1): 45-52.
|
| 28 |
陈如杰，郭献阳，程碧环，等. 阿托伐他汀对脓毒性休克患者的心肺保护作用[J/CD]. 中华危重症医学杂志（电子版），2015，8(5):291-295.
|
| 29 |
Li T, Wang D, Tian Y, et al. Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats[J]. J Neurol Sci, 2014, 341 (1-2): 88-96.
|
| 30 |
Zhang YY, Fan YC, Wang M, et al. Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease[J]. Clin Interv Aging, 2013, 8 (4): 103-110.
|
| 31 |
Naderi Y, Sabetkasaei M, Parvardeh S, et al. Neuroprotective effect of minocycline on cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory and anti-oxidant properties in male rat[J]. Brain Res Bull, 2017 (131): 207-213.
|
| 32 |
Tu Q, Cao H, Zhong W, et al. Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects[J]. Neural Regen Res, 2014, 9 (3): 268.
|
| 33 |
Ben S, Rachel G. Treatment options for chronic subdural hematoma[J]. World Neurosurg, 2016, 87 (4251): 529-530.
|
| 34 |
郭世文，闫忠军. 慢性硬膜下血肿扩大的研究进展[J]. 中华神经外科疾病研究杂志，2010，9(1):84-85.
|
| 35 |
Indraswari F, Wang H, Lei B, et al. Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach[J]. J Neurotrauma, 2012, 29 (7): 1388-1400.
|
| 36 |
Wang D, Jiang R, Liu L, et al. Membrane neovascularization and drainage of subdural hematoma in a rat model[J]. J Neurotrauma, 2010, 27 (8): 1489-1498.
|
| 37 |
Song Y, Wang Z, Liu L, et al. The level of circulating endothelial progenitor cells may be associated with the occurrence and recurrence of chronic subdural hematoma[J]. Clinics, 2013, 68 (8): 1084-1088.
|
| 38 |
Liu HF, Qi XW, Ma LL, et al. Atorvastatin improves endothelial progenitor cell function and reduces pulmonary hypertension in patients with chronic pulmonary heart disease[J]. Exp Clin Cardiol, 2013, 18 (1): e40-e43.
|
| 39 |
Oikonomou E, Siasos G, Zaromitidou M, et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients[J]. Atherosclerosis, 2015, 238 (2): 159-164.
|
| 40 |
Kageyama H, Toyooka T, Tsuzuki N, et al. Non-surgical treatment of chronic subdural hematoma with tranexamic acid[J]. J Neurosurg, 2013, 119 (2): 332-337.
|
| 41 |
Chang YY, Wu YW, Lee JK, et al. Effects of 12 weeks of atorvastatin therapy on myocardial fibrosis and circulating fibrosis biomarkers in statin-naive patients with hypertension with atherosclerosis[J]. J Invest Med, 2016, 64 (7): 1194-1199.
|
| 42 |
Wang Q, Yan J, Chen X, et al. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases[J]. Exp Neurol, 2011, 230 (1): 27-34.
|
| 43 |
Fisher M, Moonis M. Neuroprotective effects of statins: evidence from preclinical and clinical studies[J]. Curr Treat Options Cardiovasc Med, 2012, 14 (3): 252-259.
|
| 44 |
Martins WC, dos Santos VV, dos Santos AA, et al. Atorvastatin prevents cognitive deficits induced by intracerebroventricular amyloid-β1-40 administration in mice: involvement of glutamatergic and antioxidant systems[J]. Neurotox Res, 2015, 28 (1): 32-42.
|
| 45 |
李宏，金卫篷，王彬，等. 阿托伐他汀促进脑外伤小鼠血管再生改善其神经功能[J]. 中华实验外科杂志，2016，33(4):1153.
|
| 46 |
Xiong Y, Lu D, Qu C, et al. Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice[J]. J Neurosurg, 2008, 109 (3): 510-521.
|
| 47 |
Xu M, Chen P, Zhu X, et al. Effects of atorvastatin on conservative and surgical treatments of chronic subdural hematoma in patients[J]. World Neurosurg, 2016 (91): 23-28.
|
| 48 |
Shi L, Chen R, Zhang H, et al. Cerebrospinal fluid neuron specific enolase, interleukin-1β and erythropoietin concentrations in children after seizures[J]. Childs Nerv Syst, 2017, 33 (5): 805-811.
|
| 49 |
Cha YS, Kim H, Do HH, et al. Serum neuron-specific enolase as an early predictor of delayed neuropsychiatric sequelae in patients with acute carbon monoxide poisoning[J]. Hum Exp Toxicol, 2017 (1): 960327117698544.
|
| 50 |
Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury[J]. Neurology, 2004, 62 (8): 1303-1310.
|
| 51 |
Qian Z, Yang D, Sun F, et al. Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone[J]. Bri J Neurosurg, 2017, 31 (1): 84-88.
|
| 52 |
Oikonomou E, Siasos G, Zaromitidou M, et al. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients[J]. Atherosclerosis, 2015, 238 (2): 159-164.
|
| 53 |
Lin LY, Huang CC, Chen JS, et al. Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study[J]. Cardiovas Diabetol, 2014, 13 (1): 111.
|